The present invention is directed to novel non-woven fabrics containing growth and differentiation factor proteins. Said fabrics are specifically designed to accelerate tissue regeneration and wound healing processes of mammalian tissues. Furthermore, the invention provides wound dressings, pads or implants comprising the novel non-woven fabrics.

The present invention is directed to novel non-woven fabrics containing growth and differentiation factor proteins. Said fabrics are specifically designed to accelerate tissue regeneration and wound healing processes of mammalian tissues. Furthermore, the invention provides wound dressings, pads or implants comprising the novel non-woven fabrics.

Provided is a method for preventing the disturbance of vaginal bacterial flora during the menstrual period and improving the vaginal bacterial flora. One aspect of the present invention is a sanitary product carrying lactoferrin or a composition comprising lactoferrin and an auxiliary substance. Also provided is a kit comprising a sanitary product, and lactoferrin or the composition comprising lactoferrin and an auxiliary substance.

Provided is a method for preventing the disturbance of vaginal bacterial flora during the menstrual period and improving the vaginal bacterial flora. One aspect of the present invention is a sanitary product carrying lactoferrin or a composition comprising lactoferrin and an auxiliary substance. Also provided is a kit comprising a sanitary product, and lactoferrin or the composition comprising lactoferrin and an auxiliary substance.

The present disclosure relates to a collagen-alginate wound dressing, including a matrix in which a low-molecularized collagen and a low-molecularized alginate are crosslinked and a method of preparing the same.

The present disclosure includes a method of adhering an external wound dressing formed of an animal-derived bioprotein scaffolding around a site on a patient, for example, where a medical apparatus is entering the patient. The animal-derived bioprotein scaffolding can be formed of bioprotein fibers woven together. An adhesive can be integrated with the animal-derived bioprotein scaffolding and the external wound dressing can be affixed to the medical apparatus to secure the medical apparatus to the patient.

The present disclosure includes a method of adhering an external wound dressing formed of an animal-derived bioprotein scaffolding around a site on a patient, for example, where a medical apparatus is entering the patient. The animal-derived bioprotein scaffolding can be formed of bioprotein fibers woven together. An adhesive can be integrated with the animal-derived bioprotein scaffolding and the external wound dressing can be affixed to the medical apparatus to secure the medical apparatus to the patient.

Disclosed are methods of promoting wound healing in a patient in need thereof comprising administering to the patient a composition comprising a neonatal fibrin scaffold. Further disclosed are in vitro methods for evaluating a target composition on human wound healing comprising a neonatal porcine plasma scaffold with the target composition and evaluating scaffold properties of the plasma sample.

A method for treating a skin wound of a subject is described. The method includes contacting the skin wound with a therapeutically effective amount of a wound healing composition comprising glycoprotein nonmelanoma clone B (GPNMB) protein, an active peptide fragment thereof, a GPNMB analog, a GPNMB potentiating agent, or a combination thereof.

Described herewith are compositions comprising placental growth factors and methods for non-surgical, localized delivery thereof. The composition is delivered to a diseased or injured organ and/or body part and is formulated in a manner which allows for localized retention of the composition at the site of delivery.